0001415889-19-000742.txt : 20190617 0001415889-19-000742.hdr.sgml : 20190617 20190617214828 ACCESSION NUMBER: 0001415889-19-000742 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190613 FILED AS OF DATE: 20190617 DATE AS OF CHANGE: 20190617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schramm Vern Lee CENTRAL INDEX KEY: 0001719553 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37853 FILM NUMBER: 19902558 MAIL ADDRESS: STREET 1: 1300 MORRIS PARK AVE. STREET 2: BIOCHEMISTRY DEPT. CITY: BRONX STATE: NY ZIP: 10461 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AzurRx BioPharma, Inc. CENTRAL INDEX KEY: 0001604191 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 760 PARKSIDE AVENUE STREET 2: SUITE 304 CITY: BROOKLYN STATE: NY ZIP: 11226 BUSINESS PHONE: 646-699-7855 MAIL ADDRESS: STREET 1: 760 PARKSIDE AVENUE STREET 2: SUITE 304 CITY: BROOKLYN STATE: NY ZIP: 11226 FORMER COMPANY: FORMER CONFORMED NAME: BioPharma d'Azur, Inc. DATE OF NAME CHANGE: 20140331 4 1 form4-06172019_060616.xml X0306 4 2019-06-13 0001604191 AzurRx BioPharma, Inc. AZRX 0001719553 Schramm Vern Lee C/O AZURRX BIOPHARMA, INC. 760 PARKSIDE AVE STE 304 BROOKLYN NY 11226 true false false false Common Stock 2019-06-13 4 A 0 30000 0 A 75000 D Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors. /s/ Maged Shenouda, Attorney-in-Fact 2019-06-17